601 Shares in Mettler-Toledo International, Inc. $MTD Bought by Citizens Financial Group Inc. RI

Citizens Financial Group Inc. RI bought a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 601 shares of the medical instruments supplier’s stock, valued at approximately $908,000.

Other large investors have also modified their holdings of the company. Manchester Capital Management LLC boosted its stake in shares of Mettler-Toledo International by 21.5% in the third quarter. Manchester Capital Management LLC now owns 192 shares of the medical instruments supplier’s stock valued at $290,000 after buying an additional 34 shares in the last quarter. Fifth Third Wealth Advisors LLC grew its holdings in Mettler-Toledo International by 2.9% during the third quarter. Fifth Third Wealth Advisors LLC now owns 562 shares of the medical instruments supplier’s stock worth $849,000 after acquiring an additional 16 shares during the period. Yousif Capital Management LLC grew its holdings in Mettler-Toledo International by 0.7% during the third quarter. Yousif Capital Management LLC now owns 2,577 shares of the medical instruments supplier’s stock worth $3,894,000 after acquiring an additional 19 shares during the period. Root Financial Partners LLC purchased a new position in Mettler-Toledo International in the third quarter worth $56,000. Finally, Quadrant Capital Group LLC raised its position in Mettler-Toledo International by 5.4% in the third quarter. Quadrant Capital Group LLC now owns 488 shares of the medical instruments supplier’s stock worth $780,000 after acquiring an additional 25 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Up 0.8%

Mettler-Toledo International stock opened at $1,698.95 on Thursday. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. The firm has a market capitalization of $34.04 billion, a price-to-earnings ratio of 38.24, a price-to-earnings-growth ratio of 3.36 and a beta of 1.19. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,722.76. The stock’s fifty day moving average is $1,483.21 and its two-hundred day moving average is $1,338.00.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, beating analysts’ consensus estimates of $10.78 by $0.68. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the business posted $10.09 earnings per share. Analysts predict that Mettler-Toledo International, Inc. will post 47.38 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In related news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the sale, the chief executive officer directly owned 4,480 shares of the company’s stock, valued at approximately $6,384,000. This represents a 17.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Thomas Salice sold 417 shares of the firm’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $1,440.41, for a total transaction of $600,650.97. Following the transaction, the director owned 292 shares of the company’s stock, valued at $420,599.72. This trade represents a 58.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,254 shares of company stock valued at $6,092,712 over the last 90 days. 0.71% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

MTD has been the subject of a number of recent analyst reports. Rothschild & Co Redburn started coverage on Mettler-Toledo International in a report on Wednesday, September 2nd. They issued a “sell” rating and a $1,200.00 target price for the company. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, August 3rd. UBS Group began coverage on shares of Mettler-Toledo International in a report on Wednesday, September 9th. They issued a “neutral” rating and a $1,460.00 price target for the company. Weiss Ratings upgraded shares of Mettler-Toledo International from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, October 19th. Finally, Stifel Nicolaus boosted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday, August 3rd. Six analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and an average target price of $1,469.15.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc (NYSE: MTD) develops and manufactures precision instruments and related services for laboratory, industrial, and retail applications. Its products help customers weigh, measure, analyze, inspect, and control materials and processes with high accuracy.

The company’s laboratory offerings include balances and scales, analytical instruments, titration and pH systems, thermal analysis equipment, spectroscopy products, laboratory automation solutions, and associated software.